Influenza News and Research

Latest Influenza News and Research

At-home test for influenza is as accurate as rapid diagnostic testing in clinical settings

Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings, according to a recently published, peer-reviewed study.

11 Mar 2022

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Researchers defined a novel polynucleotide-based Distinctiveness metric to capture the proteome-level differences of emerging SARS-CoV-2 variants and lineages against all previously identified ones.

11 Mar 2022

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

A new study has evaluated the association of BZD use with the clinical outcomes of SARS-CoV-2 positive patients.

10 Mar 2022

Challenges and solutions for long-COVID

A recent study published in the Annals of Internal Medicine investigated the challenges and solutions associated with the unbiased estimation of post coronavirus disease 2019 (COVID-19) sequelae.

8 Mar 2022

COVID-19 may cause brain shrinkage in some people

In a recent study posted to the journal Nature as an unedited manuscript, researchers assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated brain changes among United Kingdom (UK) Biobank patients.

8 Mar 2022

Study suggests recent common cold may actually lead to worse COVID-19 disease

A new study published in the Journal of Infectious Diseases shines an unexpected light on the notion that pre-existing immunity to common cold coronaviruses can protect us from coronavirus disease 2019 (COVID-19) – and reveals that this may actually put certain individuals at risk of more severe clinical presentations.

8 Mar 2022

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Prime Minister Boris Johnson today announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42million to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 - the virus that causes COVID-19 - as well as other major coronaviruses, including those that cause SARS and MERS.

8 Mar 2022

A promising approach for COVID-19 prophylaxis

SARS-CoV-2 viruses can hide from recognition by the immune system. However, the antiviral immune receptor RIG-I can be stimulated, which improves protection against lethal SARS-CoV-2 infections.

8 Mar 2022

Development of RT-qPCR assays for differentiating SARS-CoV-2 Omicron BA.1 and BA.2 variants

In a recent study posted to the medRxiv*preprint server, a team of researchers from Israel developed and validated novel reverse transcriptase - quantitative polymerase chain reaction (RT-qPCR) assays. The new assays enable the rapid and high throughput identification and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 and BA.2 variants.

8 Mar 2022

Bacterial coinfection pervasiveness and antibiotic use in COVID-19 patients

In a recent study posted to the medRxiv* pre-print server, researchers conducted a meta-analysis to determine the bacterial coinfection and antibiotic usage prevalence in coronavirus disease 2019 (COVID-19) patients.

7 Mar 2022

World's largest genetic study reveals fresh details about severe Covid-19

The world's largest study of the genetics of critical Covid-19, involving more than 57,000 people, has revealed fresh details about some of the biological mechanisms behind the severe form of the disease.

7 Mar 2022

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Researchers from Columbia Engineering, Fiocruz's Center for Technological Development in Health and the Oswaldo Cruz Institute in Brazil, Memorial Sloan Kettering Cancer Center, and Rockefeller University recently reported that, by combining inhibitors of polymerases and exonucleases--enzymes that allow SARS-CoV-2 to reproduce--they were able to reduce SARS-CoV-2 replication 10 times more than when using just the polymerase inhibitors.

7 Mar 2022

Could oropharyngeal microflora predict COVID-19 patients' need for respiratory support?

Researchers identify oropharyngeal bacteria and metabolic pathways that are predictive of the need for respiratory support in COVID-19 patients.

7 Mar 2022

Virginia Tech-led researchers to investigate the transmission of flu in child care settings

In January, the Centers for Disease Control and Prevention (CDC) updated its guidance for reducing SARS-CoV-2 (COVID-19) transmission in schools and day care settings.

6 Mar 2022

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Scientists have recently revealed that memory T cell responses to common cold coronaviruses stably persist for a long time.

4 Mar 2022

Implementing wastewater-based Covid-19 early warning system in Germany

Coronaviruses can be detected in wastewater some days before first disease symptoms develop. On this basis, it is possible to determine the number of infections more quickly, analyze the infection situation more precisely, and identify new Covid-19 variants and their spread at an earlier stage.

4 Mar 2022

Influenza News and Research

Latest Influenza News and Research

At-home test for influenza is as accurate as rapid diagnostic testing in clinical settings

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

Challenges and solutions for long-COVID

COVID-19 may cause brain shrinkage in some people

Study suggests recent common cold may actually lead to worse COVID-19 disease

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

A promising approach for COVID-19 prophylaxis

Development of RT-qPCR assays for differentiating SARS-CoV-2 Omicron BA.1 and BA.2 variants

Bacterial coinfection pervasiveness and antibiotic use in COVID-19 patients

World's largest genetic study reveals fresh details about severe Covid-19

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Could oropharyngeal microflora predict COVID-19 patients' need for respiratory support?

Virginia Tech-led researchers to investigate the transmission of flu in child care settings

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Implementing wastewater-based Covid-19 early warning system in Germany

Dynamics of SARS-CoV-2 transmission at Purdue University

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in